Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.14
Delayed Data
As of 4:01pm ET
 -0.15 / -0.35%
Today’s Change
36.71
Today|||52-Week Range
46.10
+8.44%
Year-to-Date

Today’s Trading

Previous close43.29
Today’s open43.28
Day’s range43.00 - 43.46
Volume4,326,460
Average volume (3 months)3,716,671
Market cap$104.5B
Dividend yield5.42%
Data as of 4:01pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+14.18%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-3.66%
P/E ratio171.7
Price/Sales2.70
Price/Book13.78

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.31-0.75%
NVONovo Nordisk-1.14-2.04%
ABBVAbbVie+0.33+0.54%
BMYBristol-Myers Squibb-0.83-1.15%
Data as of 4:02pm ET, 05/03/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs